GANÉ Aktiengesellschaft | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Headlines Articles Press releases GANÉ Aktiengesellschaft

Home
Companies
GANÉ Aktiengesellschaft

BRIEF

published on 03/12/2024 at 14:50, 8 months 8 days ago

GANÉ Aktiengesellschaft Announces New Share Classes and Fund Name Change

GANÉ Aktiengesellschaft Share Classes BaFin Investment Fund Value Event Fund
PRESS RELEASE

published on 03/12/2024 at 14:45, 8 months 8 days ago

Additional share classes offered for GANÉ Value Event Fund, name change effective as of 2 April 2024
GANÉ Aktiengesellschaft offers new share classes for GANÉ Value Event Fund, with name change effective from 2 April 2024, following approval by BaFin

GANÉ Aktiengesellschaft Name Change Share Classes GANÉ Value Event Fund BaFin Approval
BRIEF

published on 02/20/2024 at 10:00, 9 months 1 day ago

The GANÉ Global Balanced Fund evolves into the GANÉ Value Event Fund

GANÉ Investment Fund Value Event Aggressive Strategy Fund Change
PRESS RELEASE

published on 02/20/2024 at 10:00, 9 months 1 day ago

GANÉ Global Balanced Fund becomes GANÉ Value Event Fund
GANÉ launches the GANÉ Value Event Fund, changing the GANÉ Global Balanced Fund's investment concept from defensive to offensive, following a successful model. More details and adjustments explained

GANÉ Value Event Fund Investment Concept Defensive To Offensive Fund Management Adjustments
PRESS RELEASE

published on 01/22/2024 at 09:00, 9 months 30 days ago

GANÉ Aktiengesellschaft: Dr Uwe Rathausky and J. Henrik Muhle named Fund Manager of the Year 2024
GANÉ Aktiengesellschaft's Directors and Fund Advisors, Dr Uwe Rathausky and J. Henrik Muhle, have been honored with the 'Fund Manager of the Year 2024' award by Finanzen Verlag for their exceptional performance. The award recognizes their successful management of the GANÉ Global Equity Fund and ACATIS GANÉ Value Event Fund, underpinned by their unique value and event investment strategy. This achievement reflects their dedication to delivering excellent results for investors and their commitment to long-term success in the market. For more information, visit www.gane.de.

GANÉ Aktiengesellschaft Dr Uwe Rathausky J. Henrik Muhle Fund Manager Of The Year Value Investment

Accesswire

Published on 11/21/2024 at 10:03, 27 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 30 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 30 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 55 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 5 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 25 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 28 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 30 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 30 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 29 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 10 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 45 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 45 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE